Less Ads, More Data, More Tools Register for FREE

IP Group increases buyback programme by £10m

Thu, 08th Aug 2024 09:18

(Sharecast News) - Intellectual property business IP Group said on Thursday that it would increase its current share buyback programme as a result of cash proceeds from H1 exits coming in ahead of the prior year.

IP Group stated that following a "strong performance" on portfolio realisations during the year to date, cash proceeds from exits confirmed or completed now totalled over £43.0m - already exceeding the group's FY23 total.

The FTSE 250-listed company said its previously announced sale of Garrison Technology to US-based cybersecurity firm Everfox was expected to complete during August and added that portfolio business Intelligent Ultrasound Group planned to make a "material return of capital" following the announced sale of its Clinical AI business to GE HealthCare for an enterprise value of £40.5m.

As a result, IP Group plans to up its current share buyback programme by a further £10.0m, increasing it to a total of £30.0m.

IP Group intends to publish its results for the six months ended 30 June on 17 September.

As of 0915 BST, IP Group shares were down 0.41% at 36.0p.

Reporting by Iain Gilbert at Sharecast.com

Ip Group

Shares in this article

Related News

WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track
3 Jun 2026

WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.

IP Group cheers trial results for Enterprise drug candidate
12 May 2026

IP Group cheers trial results for Enterprise drug candidate

(Alliance News) - IP Group PLC on Monday noted positive test results for a cystic fibrosis treatment developed by one of its portfolio firms.

IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint
7 May 2026

IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint

IP Group PLC - London-based investor in "breakthrough" science and technology firms - Appoints Michael Queen as chair designate, and as a non-executi...

Corporate News Ip Group + 1 more share